RDIF

The Sputnik V vaccine helps San Marino to become the first country in Europe to defeat COVID and reduce the infection rate to zero

MOSCOW, May 10, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces positive results achieved by San Marino in the fight against coronavirus thanks to the Russian Sputnik V vaccine with infection rate having fallen to zero level. This has enabled the authorities to start lifting COVID restrictions, restore economic activity and return to normal life.

San Marino was able to roll out the most successful vaccination campaign in Europe thanks to Sputnik V: average 7-day infection rate per 1 mn people (May 3-9) is more than 40 times lower than that in the EU countries. Positive results of the vaccination campaign with Sputnik V were obtained only two months after it started with the median daily COVID cases dropping by 250 times from a highest point in early April to zero level and no cases of infection registered since May 4th.

In San Marino 74% of population of 16+ have been vaccinated with the first dose of a COVID vaccine whereas 90% of those vaccinations were conducted using  Sputnik V. Vaccination in San Marino has also helped to eliminate death cases caused by COVID. San Marino closed its hospital ward for treatment of patients infected with coronavirus.

The profound results prove Sputnik V's effectiveness against the British strain that is currently spreading across Europe, including in neighboring Italy.

RDIF is ready to provide additional batches of Sputnik V to San Marino to arrange vaccine tourism based on positive vaccination results in the country which demonstrated a sharp decrease of the infection rate to zero.

Post-vaccination studies in a number of countries, including Argentina, Mexico and Hungary, have demonstrated that Sputnik V is the safest and most effective vaccine against coronavirus. Sputnik V is registered in 64 countries around the world with total population of over 3.2 billion people. Sputnik V ranks second among coronavirus vaccines globally in terms of the number of approvals issued by government regulators.

Sputnik V has been approved in Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, UAE, Iran, Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua, Republika Srpska (entity of Bosnia and Herzegovina), Lebanon, Myanmar, Pakistan, Mongolia, Bahrain, Montenegro, Saint Vincent and the Grenadines, Kazakhstan, Uzbekistan, Gabon, San-Marino, Ghana, Syria, Kyrgyzstan, Guyana, Egypt, Honduras, Guatemala, Moldova, Slovakia, Angola, Republic of the Congo, Djibouti, Sri Lanka, Laos, Iraq, North Macedonia, Kenya, Morocco, Jordan, Namibia, Azerbaijan, Philippines, Cameroon, Seychelles, Mauritius, Vietnam, Antigua and Barbuda, Mali, Panama, India, Nepal, Bangladesh, Turkey and Albania.